Sort
50,496 grants matching “lung cancer”
The potential risks and benefits of electronic cigarettes to older smokers at high risk for lung cancer
$638,439Jason D Robinson · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Development of novel selective Rac inhibitors for refractory leukemias
$638,223David A Williams · Boston Children'S Hospital · R01 · FY2016 · CA
Structurally dissecting APOBEC3's for HIV-1 restriction and beyond
$638,187Celia A. Schiffer · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · AI
Lung cancer molecular markers by sex: intergroup study
$638,179Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2006 · CA
Detecting and locating cancer for patients with CT-detected lung nodules
$638,167Xianghong Jasmine Zhou · University Of California Los Angeles · R01 · FY2023 · CA
Modulating the localization and persistence of microbial neoantigen vaccine vectors to enhance therapeutic efficacy
$638,120Nicholas Arpaia · Columbia University Health Sciences · R01 · FY2025 · CA
Role of Selenium-containing Proteins in Cancer
$638,093Dolph Hatfield · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Canadian Fluoroscopy Cohort Study: Lifespan Mortality and Incidence Follow-Up
$637,988Lydia B Zablotska · University Of California, San Francisco · R01 · FY2019 · CA
Speckle x-ray imaging: detecting early changes in lung microstructure
$637,860Peter B Noãl · University Of Pennsylvania · R01 · FY2023 · HL
Development and Dissemination of Clinical CEST MRI Acquisition and Analysis Methods for Cancer Imaging Applications
$637,830Mark David Pagel · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy
$637,797Dejana K Braithwaite · University Of Florida · R01 · FY2025 · CA
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
$637,769Wendy M Leisenring · Fred Hutchinson Cancer Research Center · R01 · FY2013 · CA
NOVEL THERAPY STRATEGIES FOR MESENCHYMAL NON-SMALL CELL LUNG CANCER
$637,737The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2017 · Department of the Army
Prevention of pelvic floor muscle dysfunction with extracellular matrix hydrogel
$637,646Marianna Alperin · University Of California, San Diego · R01 · FY2022 · HD
Prevention of pelvic floor muscle dysfunction with extracellular matrix hydrogel
$637,646Marianna Alperin · University Of California, San Diego · R01 · FY2023 · HD
Prevention of pelvic floor muscle dysfunction with extracellular matrix hydrogel
$637,646Marianna Alperin · University Of California, San Diego · R01 · FY2021 · HD
Targeting Alterations of the NOTCH1 Pathway in Head & Neck Squamous Cell Carcinoma (HNSCC)
$637,606Faye Johnson · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Targeting Alterations of the NOTCH1 Pathway in Head & Neck Squamous Cell Carcinoma (HNSCC)
$637,606Faye Johnson · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy
$637,512Dejana K Braithwaite · University Of Florida · R01 · FY2021 · CA
Enabling new translational discoveries using a genomic data-driven nosology
$637,505Atul J Butte · Stanford University · R01 · FY2014 · GM
Metabolic activation of nitroarenes and Nrf2-Keap1
$637,502Trevor M. Penning · University Of Pennsylvania · R01 · FY2025 · ES
Structural and molecular determinants of protein phosphatase 2A function in lung cancer
$637,453Goutham Narla · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Mechanisms of Durable Antitumor Immunity Mediated by PI3K-targeted T cells
$637,418Chrystal Mary Paulos · Emory University · R01 · FY2023 · CA
Regulatory immune cells in immune suppression: The role of tBregs
$637,389Arya Biragyn · National Institute On Aging · ZIA · FY2019 · AG
Engineering high performing microfluidic system for rapid non-invasive isolation and expansion of circulating tumor-reactive lymphocytes
$637,371Shana O Kelley · Northwestern University At Chicago · R01 · FY2025 · CA